K
Konstantinos Kontzoglou
Researcher at National and Kapodistrian University of Athens
Publications - 144
Citations - 2590
Konstantinos Kontzoglou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 24, co-authored 129 publications receiving 1869 citations. Previous affiliations of Konstantinos Kontzoglou include Athens State University.
Papers
More filters
Journal ArticleDOI
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
Dimitrios Dimitroulis,Christos Damaskos,Serena Valsami,Spyridon Davakis,Nikolaos Garmpis,Eleftherios Spartalis,Antonios Athanasiou,Demetrios Moris,Stratigoula Sakellariou,Stylianos Kykalos,Gerasimos Tsourouflis,Anna Garmpi,Ioanna Delladetsima,Konstantinos Kontzoglou,Gregory Kouraklis +14 more
TL;DR: The current evidence on epidemiology, symptomatology, diagnosis and treatment of hepatocellular carcinoma is described, which remains a challenge to early diagnose, and treat effectively.
Journal ArticleDOI
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
Christos Damaskos,Serena Valsami,Michael C. Kontos,Eleftherios Spartalis,Theodoros Kalampokas,Emmanouil Kalampokas,Antonios Athanasiou,Demetrios Moris,A. Daskalopoulou,Spyridon Davakis,Gerasimos Tsourouflis,Konstantinos Kontzoglou,Despina Perrea,Nikolaos Nikiteas,Dimitrios Dimitroulis +14 more
TL;DR: The use of HDAC inhibitors as anticancer treatment and the mechanisms of therapeutic effects on breast cancer are explained and further clinical benefits of this new class of drugs are anticipated.
Journal ArticleDOI
Correlation between Ki67 and breast cancer prognosis.
Konstantinos Kontzoglou,Victoria Palla,George Karaolanis,Ioannis Karaiskos,Ioannis Alexiou,Ioannis S. Pateras,Konstantinos Konstantoudakis,Michael Stamatakos +7 more
TL;DR: The debate on the prognostic role of Ki67 in breast cancer is still open, although most of the studies have established a relation between Ki67 and overall and disease-free survival.
Journal ArticleDOI
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
Narjes Nasiri-Ansari,Chrysa Nikolopoulou,Katerina Papoutsi,Ioannis Kyrou,Ioannis Kyrou,Ioannis Kyrou,Christos S. Mantzoros,Christos S. Mantzoros,Georgios Kyriakopoulos,Antonios Chatzigeorgiou,Vassiliki Kalotychou,Manpal S. Randeva,Kamaljit Chatha,Konstantinos Kontzoglou,Gregory Kaltsas,Athanasios G. Papavassiliou,Harpal S. Randeva,Harpal S. Randeva,Harpal S. Randeva,Eva Kassi +19 more
TL;DR: In this article, empagliflozin treatment for five weeks attenuates NAFLD progression in ApoE(-/-) mice by promoting autophagy, reducing ER stress and inhibiting hepatic apoptosis.
Journal ArticleDOI
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
Nikolaos Garmpis,Christos Damaskos,Anna Garmpi,Emmanouil Kalampokas,Theodoros Kalampokas,Eleftherios Spartalis,A. Daskalopoulou,Serena Valsami,Michael C. Kontos,Afroditi Nonni,Konstantinos Kontzoglou,Despina Perrea,Nikolaos Nikiteas,Dimitrios Dimitroulis +13 more
TL;DR: More studies concerning HDAC inhibitors in breast carcinomas along with a more accurate understanding of the TNBC's pathobiology are required for the possible identification of new therapeutic strategies.